Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)Pieter J. Gaillard, Olaf van Tellingen, Helga E. de Vries et al.|PLoS ONE|2014Cited by 280
Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancerPieter J. Gaillard, Olaf van Tellingen, Werner Gladdines et al.|Cancer Research|2012Cited by 15
NT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)Bojana Milojkovic Kerklaan, Dieta Brandsma, Agnes Jager et al.|Neuro-Oncology|2014Cited by 14
Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastasesPhilippe Aftimos, Dieta Brandsma, Bojana Milojkovic-Kerklaan et al.|Cancer Research|2015Cited by 6